npj Precision Oncology, Published online: 15 November 2026; doi:10.1038/s41698-026-01803-5 LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors
Yuli Zhou, Xueqin Wu, Fang Wang, Siren Feng, Luying Zhang, Kun Liu et al. LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors. // npj Precision Oncology. – 2026. – DOI: 10.1038/s41698-026-01803-5. – URL: https://www.nature.com/articles/s41698-026-01803-5
Yuli Zhou, Xueqin Wu, Fang Wang, Siren Feng, Luying Zhang, Kun Liu, Junnv Xu, Bo Lin, Mingyue Zhu, & Mengsen Li (2026). LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01803-5
Yuli Zhou, et al. “LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors.” npj Precision Oncology, 2026. doi:10.1038/s41698-026-01803-5.
@article{Zhou2026,
title = {LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors},
author = {Zhou, Yuli and Wu, Xueqin and Wang, Fang and Feng, Siren and Zhang, Luying and Liu, Kun and Xu, Junnv and Lin, Bo and Zhu, Mingyue and Li, Mengsen},
journal = {npj Precision Oncology},
year = {2026},
doi = {10.1038/s41698-026-01803-5},
url = {https://www.nature.com/articles/s41698-026-01803-5}
}